Splicing Factor SRSF1 Promotes Pancreatitis and KRASG12D-Mediated Pancreatic Cancer
Cancer Discovery · 2023
DOI: 10.1158/2159-8290.cd-22-1013 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Discovery, 2023. Verfasst von Ledong Wan und 9 weiteren Autor:innen. Beteiligte Einrichtung: Cold Spring Harbor Laboratory, Cold Spring Harbor, New York. Hauptthemen laut MEDLINE: Carcinoma, Pancreatic Ductal, Pancreatic Neoplasms, Pancreatitis. Die Arbeit wurde bisher 74-mal zitiert (Crossref) und nennt 89 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS, NIH HHS, Lustgarten Foundation.
Abstract (Originalsprache)
Inflammation is strongly associated with pancreatic ductal adenocarcinoma (PDAC), a highly lethal malignancy. Dysregulated RNA splicing factors have been widely reported in tumorigenesis, but their involvement in pancreatitis and PDAC is not well understood. Here, we report that the splicing factor SRSF1 is highly expressed in pancreatitis, PDAC precursor lesions, and tumors. Increased SRSF1 is sufficient to induce pancreatitis and accelerate KRASG12D-mediated PDAC. Mechanistically, SRSF1 activates MAPK signaling—partly by upregulating interleukin 1 receptor type 1 (IL1R1) through alternative-splicing-regulated mRNA stability. Additionally, SRSF1 protein is destabilized through a negative feedback mechanism in phenotypically normal epithelial cells expressing KRASG12D in mouse pancreas and in pancreas organoids acutely expressing KRASG12D, buffering MAPK signaling and maintaining pancreas cell homeostasis. This negative feedback regulation of SRSF1 is overcome by hyperactive MYC, facilitating PDAC tumorigenesis. Our findings implicate SRSF1 in the etiology of pancreatitis and PDAC, and point to SRSF1-misregulated alternative splicing as a potential therapeutic target. Significance: We describe the regulation of splicing factor SRSF1 expression in the context of pancreas cell identity, plasticity, and inflammation. SRSF1 protein downregulation is involved in a negative feedback cellular response to KRASG12D expression, contributing to pancreas cell homeostasis. Conversely, upregulated SRSF1 promotes pancreatitis and accelerates KRASG12D-mediated tumorigenesis through enhanced IL1 and MAPK signaling. This article is highlighted in the In This Issue feature, p. 1501
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Cold Spring Harbor Laboratory, Cold Spring Harbor, New York.
- Department of Pathology, University of Michigan, Ann Arbor, Michigan.
- Lustgarten Foundation Pancreatic Cancer Research Laboratory, Cold Spring Harbor, New York.
ORCID-Profile: Ledong Wan, Kuan-Ting Lin, Mohammad Alinoor Rahman, Yuma Ishigami, Zhikai Wang, Mads A Jensen, John E Wilkinson, Youngkyu Park, David A Tuveson, Adrian R Krainer
Förderung
- NCI NIH HHS
- NIH HHS
- Lustgarten Foundation
- St. Giles Foundation
- National Cancer Institute
- National Institutes of Health
Zitieren
APA
Wan, L., Lin, K. T., Rahman, M. A., Ishigami, Y., Wang, Z., Jensen, M. A., Wilkinson, J. E., Park, Y., Tuveson, D. A., & Krainer, A. R. (2023). Splicing Factor SRSF1 Promotes Pancreatitis and KRASG12D-Mediated Pancreatic Cancer. Cancer Discovery. https://doi.org/10.1158/2159-8290.cd-22-1013
Vancouver
Wan L, Lin KT, Rahman MA, Ishigami Y, Wang Z, Jensen MA, et al. Splicing Factor SRSF1 Promotes Pancreatitis and KRASG12D-Mediated Pancreatic Cancer. Cancer Discovery. 2023. doi:10.1158/2159-8290.cd-22-1013
BibTeX
@article{Wan2023,
author = {Wan, Ledong and Lin, Kuan-Ting and Rahman, Mohammad Alinoor and Ishigami, Yuma and Wang, Zhikai and Jensen, Mads A and Wilkinson, John E and Park, Youngkyu and Tuveson, David A and Krainer, Adrian R},
title = {Splicing Factor SRSF1 Promotes Pancreatitis and KRASG12D-Mediated Pancreatic Cancer},
journal = {Cancer Discovery},
year = {2023},
doi = {10.1158/2159-8290.cd-22-1013}
}
EUVIMED